Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT02378883
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 112 participants
- Registry
-
NCT02378883
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02378883. Allocation not applicable; no masking; primary purpose treatment. Start 2015-05-18 (actual); primary completion 2018-02-20 (actual). Results posted on 2019-04-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
- Condition
- Arteriovenous Malformations
- Intervention (Device)
- Apollo™ Onyx™ Delivery Micro Catheter
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
Record details
- Record id
cardio:ct-nct02378883- Content hash
b55e5159be0bb7c78d2c2bdaa54eeae927abc1b429080af6ddfe6d54c616795d